Viridian Therapeutics Inc (VRDN)
13.51
-0.40
(-2.88%)
USD |
NASDAQ |
May 10, 11:00
Viridian Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | 8.47% |
| September 30, 2016 | 32.62% |
| June 30, 2016 | 28.15% |
| March 31, 2016 | 23.11% |
| December 31, 2015 | 30.80% |
| September 30, 2015 | -15.17% |
| June 30, 2015 | 7.63% |
| March 31, 2015 | -17.83% |
| Date | Value |
|---|---|
| December 31, 2014 | -19.24% |
| September 30, 2014 | 30.82% |
| June 30, 2014 | 25.12% |
| March 31, 2014 | 33.00% |
| December 31, 2013 | 38.75% |
| September 30, 2013 | 27.49% |
| June 30, 2013 | 45.32% |
| March 31, 2013 | 41.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
| Myomo Inc | 65.28% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.52% |
| Return on Assets | -59.66% |
| Return on Invested Capital | -64.56% |
| Profit Margin (Quarterly) | -92.86K% |
| Operating Margin (Quarterly) | -99.28K% |
| Return on Net Operating Assets | -6.80K% |